PET/CT in oncology--a major advance

Area of Science:

• Medical Imaging
• Radiology
• Oncology

Background:

• Hardware-accelerated Positron Emission Tomography/Computed Tomography (PET/CT) is a recent advancement in medical imaging, commercially available for approximately four years.
• The integration of PET and CT in a single hardware platform offers distinct advantages over standalone PET imaging.

Purpose of the Study:

• To review the strengths and weaknesses of PET/CT technology.
• To evaluate the current evidence supporting the use of PET/CT in oncology.
• To discuss the future directions and potential applications of PET/CT.

Main Methods:

• Literature review of studies on PET/CT in oncology.
• Analysis of clinical evidence for staging, re-staging, and follow-up of cancer patients.
• Assessment of the impact of PET/CT on patient management plans.

Main Results:

• PET/CT provides complementary information crucial for accurate cancer staging and re-staging.
• Evidence indicates that PET/CT significantly influences management decisions in oncology.
• The combined modality offers enhanced diagnostic capabilities compared to PET alone.

Conclusions:

• PET/CT has become an invaluable tool in modern oncology practice.
• Further research and technological development are expected to expand the role of PET/CT.
• The review highlights the evolving landscape and future potential of integrated PET/CT imaging.